Recursion Pharmaceuticals Inc (RXRX)

Recursion Pharmaceuticals Inc (RXRX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.9B; returns 1 day +3.4%, 1 week +6.8%, 1 year -35.4%.

Recursion Pharmaceuticals, Inc. (RXRX) is a clinical-stage TechBio company that leverages artificial intelligence (AI) and machine learning to decode biology and discover novel therapeutics. Unlike traditional pharmaceutical R&D, Recursion generates and analyzes biological data at an unprecedented scale using its Recursion OS platform.

Groups RXRX belongs to

• Artificial Intelligence
• Drug Discovery
• Machine Learning
• AI in Healthcare
• Biotechnology
• Clinical Stage Biotech
• Healthcare Technology
• Technology Sector
• Healthcare Innovation
• Life Sciences
• Data Analytics
• Biopharmaceutical
• Big Data

RXRX financial model: income statement, cash flow and balance sheet